𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sequential FDG-PET/CT after Neoadjuvant Chemotherapy is a Predictor of Histopathologic Response in Patients with Head and Neck Squamous Cell Carcinoma

✍ Scribed by Masahiro Kikuchi; Shogo Shinohara; Yuji Nakamoto; Yu Usami; Keizo Fujiwara; Tsunemichi Adachi; Shin-ya Hori; Yosuke Tona; Hiroshi Yamazaki; Yukihiro Imai; Yasushi Naito


Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
316 KB
Volume
13
Category
Article
ISSN
1536-1632

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


18F-FDG-PET/CT versus panendoscopy for t
✍ Stephan K. Haerle; Klaus Strobel; Thomas F. Hany; Daniel Sidler; Sandro J. Stoec πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 2 views

## Abstract ## Background. This study assesses the additional value of ^18^F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography/CT (^18^F‐FDG‐PET/CT) with respect to synchronous primaries in patients undergoing panendoscopy for staging of head and neck squamous cell carcinoma. ## Methods. In

Use of integrated 18F-FDG PET/CT to impr
✍ Han-Sin Jeong; Chung-Hwan Baek; Young-Ik Son; Man Ki Chung; Dong Kyung Lee; Joon πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 656 KB

## Abstract ## Background. We investigated the accuracy of performing cervical nodal evaluation with using integrated ^18^F‐fluoro deoxyglucose positron emission tomography (PET)/CT for squamous cell carcinoma (SCC) of the head and neck as compared with using PET and contrast‐enhanced CT (CECT) al

A Phase I/II trial of concurrent docetax
✍ Roy B. Tishler; Charles M. Norris Jr.; A. Dimitrios Colevas; Carolyn C. Lamb; Da πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The authors conducted a Phase I/II study in patients with a poor prognosis who had locally advanced squamous cell carcinoma of the head and neck (SCCHN) and who were treated initially with induction chemotherapy. Patients were treated with weekly docetaxel and concurrent